- Home
- Companies
- north america
- pancreatitis
Show results for
Refine by
Pancreatitis Suppliers In North America
82 companies found
based inFederal Way, WASHINGTON (USA)
Established in 1987, DiagnosTechs was the first laboratory to introduce saliva hormone testing into routine clinical practice. In 1995, DiagnosTechs added saliva and stool-based gastrointestinal and food sensitivity testing, which expanded the level ...
based inMonmouth Junction, NEW JERSEY (USA)
CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 58 countries around the world, as an extracorporeal ...
based inCondell Park, AUSTRALIA
Next Instruments manufactures a range of innovative analytical and process instruments for the food, agriculture, human nutrition and medical research. Next Instruments is an Australian owned family company that has been developing innovative ...
based inSTAFFORD SPRINGS, CONNECTICUT (USA)
Hobbs Medical is a privately held, Hispanic woman-owned company specializing in the design, manufacture, and distribution of precision instruments and accessories for gastrointestinal (GI) and pulmonary endoscopy. Founded in 1984 and headquartered ...
Spray Catheters, delivering a comprehensive 360-degree spray mist, are employed in Chromoendoscopy and irrigation procedures. Push Catheters support therapeutic ERCP for the precise placement of biliary and pancreatic stents. These ...
based inMadison, WISCONSIN (USA)
Privately-owned company operating in Madison, Wisconsin (MG&E Innovation Center) and Chicago, Illinois. Team of experts in the field of stem cell research which allows RMS to make unprecedented scientific breakthroughs. Extensive experience in stem ...
We are developing autologous and allogeneic versions of ILC cellular therapeutic. In the case of autologous ILC cellular therapeutic we will convert the diabetes patients own cells into iPSC cells followed by differentiation of the patient derived ...
based inWarrington, UNITED KINGDOM
More than 40 years of design, development and manufacture of quadrupole mass spectrometers. We design, develop and manufacture quadrupole mass spectrometers for advanced research applications and specialist process monitoring. Our quadrupole mass ...
based inCarlsbad, CALIFORNIA (USA)
Qualigen is a biotechnology company focused on the development of novel therapeutic products for the treatment of cancer and infectious diseases, as well as expansion of its flagship FastPack diagnostic platform. The FastPack line of FDA-cleared and ...
RAS itself acts as a “hub” that activates multiple effector pathways and blocking any single pathway is ineffective for many tumor types, including pancreatic, lung, and colorectal ...
based inBeachwood, OHIO (USA)
We develop cell therapies - at a dramatically increased speed, at lower cost, and with less R&D risk. Trailhead Biosystems merges developmental biology and cell therapeutics with cutting-edge hardware and computerized experimental design and ...
based inParsippany, NEW JERSEY (USA)
Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Since our ...
Our laboratory, located in Pittsburgh, Pennsylvania is Clinical Laboratory Improvement Amendment (CLIA) certified and College of American Pathologists (CAP) accredited. Additionally, we house one of the largest repositories of ...
based inShirley, MASSACHUSETTS (USA)
In 2022, we became part of Absolute Biotech, a new company that unites multiple life science brands into one organization specializing in antibody reagents and services. Learn more at absolutebiotech.com. The extensive LSBio reagent catalog contains ...
LTB4R2 is a low-affinity receptor for leukotrienes including leukotriene B4. It mediates the chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. ...
based inGolden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
Human Pancreatic Fibroblasts. Cryopreserved at a low passage. High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1-optimized for high growth rates, reduced doubling times, ...
based inHouston, TEXAS (USA)
CUSABIO is a National High-Tech Enterprise with research, production and sales in one. After 16 years of effort, CUSABIO has become a good partner to researchers through worldwide. We are dedicated to providing 60,000+ validated antibodies, 10,000+ ...
based inAlameda, CALIFORNIA (USA)
Fluxion delivers advanced solutions that transform complex cell-based and cell-free assays. Leading labs across the globe rely on Fluxion's instruments, kits, and lab services to research novel biology, accelerate drug discovery, and tailor ...
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. ...
based inCarlsbad, CALIFORNIA (USA)
The Global Leader in Human Trophoblast Stem Cells [hTSCs] for Allogeneic Cell Therapies. Accelerated Biosciences is a regenerative medicine company. We are sourcing the highest quality immune-privileged human Trophoblast Stem Cells (hTSCs) with no ...
Stem cells possess two defining characteristics that give potential to address unmet medical needs in healthcare: 1) the ability to self-replicate throughout the life of an organism and 2) the ability to differentiate to many different cell types in ...
based inSan Diego, CALIFORNIA (USA)
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, ...
based inPalmyra, WISCONSIN (USA)
Standard Process is a third generation, family-owned company that works with health care practitioners to effectively and holistically enhance wellness for the entire family. We’ve dedicated ourselves to changing lives through whole food-based ...
based inNew York, NEW YORK (USA)
Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in ...
Glucagon-like peptide-1 (GLP-1) is an incretin derived from the transcription product of the proglucagon gene. The major source of GLP-1 in the body is the intestinal L cell that secretes GLP-1 as a gut hormone. Its physiological functions include ...
based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
RHB-107 (INN: upamostat) (formerly MESUPRON) is a first-in-class, once-daily, orally-administered, potent inhibitor of serine proteases targeting multiple indications, including COVID-19, cancer, inflammatory lung diseases and gastrointestinal ...
based inCrumlin, UNITED KINGDOM
A global market leader within the in vitro diagnostics industry, Randox Laboratories develops innovative diagnostic solutions for hospitals, clinical, research and molecular labs, food testing, forensic toxicology, veterinary labs and life sciences. ...
The Randox range of clinical chemistry reagents is extensive with a wide range of assays to suit your needs. Investing heavily in research and development, we continuously expand our portfolio to ensure increased choice of high quality reagents. ...
based inToronto, ONTARIO (CANADA)
Zucara Therapeutics is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes. This pre-clinical technology is directed at regulating a hormone in the pancreas called somatostatin which in Type ...
Zucara Therapeutics is developing ZT-01, a first-in-class, once-daily therapeutic to prevent insulin-induced hypoglycemia in patients using insulin therapy. ZT-01 is designed to inhibit somatostatin, a pancreatic hormone that ...